News
Public · Published
Merit Medical Price Target Raised to $92.00/Share From $83.00 by Wells Fargo
Wells Fargo raised its price target on Merit Medical to $92.00 per share from $83.00 and maintained its Equal-Weight rating on the stock, according to a Benzinga ratings summary.
Published:
Updated:
What happened
Wells Fargo raised its price target on Merit Medical to $92.00 per share from $83.00 and maintained its Equal-Weight rating on the stock, according to a Benzinga ratings summary.
Confirmed
Global impact / market context
A higher price target signals the analyst sees more value in Merit Medical, while Equal-Weight means the stock is expected to perform roughly in line with peers. This update alone does not change that relative view.
Analyst inference
The target increase implies the analyst expects Merit Medical shares to trade above earlier assumptions. Investors could read this as modestly positive, but the unchanged Equal-Weight rating means it is not a strong buy signal.
Analyst inference
What to watch
- Whether Wells Fargo's Equal-Weight rating on Merit Medical remains unchanged after this price target increase, since the article lists both actions. Confirmed
- Watch for further analyst notes from other firms on Merit Medical to see whether a broader pattern of price target revisions develops. Proposed
- Track Merit Medical's next earnings report, because stronger revenue or profit could justify the higher target and support the share price. Analyst inference
Evidence
- Original source link unavailable